Study identifier:D1843R00050
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
An Observational, Cross sectional Study to assess the prevalence of chronic kidney disease in Type 2 Diabetes Patients in India
diabetes
N/A
No
-
All
3000
Observational
N/A
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verified 01 Mar 2016 by AstraZeneca
AstraZeneca
NO
No locations available
Arms | Assigned Interventions |
---|---|
T2DM patients with Chronic Kidney Disease T2DM patients with Chronic Kidney Disease | - |